Literature DB >> 27092984

Nanoscale bioactive glass activates osteoclastic differentiation of RAW 264.7 cells.

Rainer Detsch1, Matthias Rübner2, Pamela L Strissel2, Dirk Mohn3,4, Erwin Strasser5, Wendelin J Stark3, Reiner Strick2, Aldo R Boccaccini1.   

Abstract

BACKGROUND: There is limited knowledge regarding differentiation of osteoclasts in the presence of nanoscale bioactive glass (nBG). This investigation examined increasing concentrations of 45S5 nBG and their influence on osteoclast differentiation. MATERIALS &
METHODS: Different concentrations of 45S5 nBG were cultured up to 14 days with the murine RAW264.7 cell line and human primary monocytes cultured with M-CSF and RANKL.
RESULTS: Culturing cells for 14 days with 500 μg/ml nBG showed a viability of 100%; however DNA synthesis was reduced, supporting differentiation into osteoclast-like cells. Using RAW cells, activation of nine genes, including cell fusion genes, occurred in an nBG concentration dependent manner. Low concentrations of nBG increased expression of genes involved in commitment to cell fusion, whereas high concentrations increased gene expression supporting osteoclast-like differentiation.
CONCLUSION: nBG enhances both RAW264.7 and human osteoclast differentiation. nBG controlled gene expression in a concentration dependent manner could reflect normal regulation during bone growth.

Entities:  

Keywords:  bioactive glass; biomaterials; bone tissue engineering; nanoparticles; osteoclasts

Mesh:

Substances:

Year:  2016        PMID: 27092984     DOI: 10.2217/nnm.16.20

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  6 in total

Review 1.  Use of nanoparticles in skeletal tissue regeneration and engineering.

Authors:  Miriam Filippi; Gordian Born; Delphine Felder-Flesch; Arnaud Scherberich
Journal:  Histol Histopathol       Date:  2019-11-13       Impact factor: 2.303

2.  Tobacco Mosaic Viral Nanoparticle Inhibited Osteoclastogenesis Through Inhibiting mTOR/AKT Signaling.

Authors:  Zhongshu Shan; Hongtao Bi; Angxiu Suonan; Yong Gu; Huan Zhou; Kun Xi; Rui Xiong; Hua Chen; Liang Chen
Journal:  Int J Nanomedicine       Date:  2020-09-29

3.  Engineering of L-Plastin Peptide-Loaded Biodegradable Nanoparticles for Sustained Delivery and Suppression of Osteoclast Function In Vitro.

Authors:  Sunipa Majumdar; Aniket S Wadajkar; Hanan Aljohani; Mark A Reynolds; Anthony J Kim; Meenakshi Chellaiah
Journal:  Int J Cell Biol       Date:  2019-05-05

4.  Supplementation with 45S5 Bioactive Glass Reduces In Vivo Resorption of the β-Tricalcium-Phosphate-Based Bone Substitute Material Vitoss.

Authors:  Fabian Westhauser; Christopher Essers; Maria Karadjian; Bruno Reible; Gerhard Schmidmaier; Sébastien Hagmann; Arash Moghaddam
Journal:  Int J Mol Sci       Date:  2019-08-30       Impact factor: 5.923

5.  The inhibitory effect of melatonin on osteoclastogenesis of RAW 264.7 cells in low concentrations of RANKL and MCSF.

Authors:  Hala Jarrar; Damla Çetİn Altindal; Menemşe GÜmÜŞderelİoĞlu
Journal:  Turk J Biol       Date:  2020-12-14

6.  Encapsulation of Rat Bone Marrow Derived Mesenchymal Stem Cells in Alginate Dialdehyde/Gelatin Microbeads with and without Nanoscaled Bioactive Glass for In Vivo Bone Tissue Engineering.

Authors:  Ulrike Rottensteiner-Brandl; Rainer Detsch; Bapi Sarker; Lara Lingens; Katrin Köhn; Ulrich Kneser; Anja K Bosserhoff; Raymund E Horch; Aldo R Boccaccini; Andreas Arkudas
Journal:  Materials (Basel)       Date:  2018-10-01       Impact factor: 3.623

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.